ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Skin Patch Medicine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38M16213
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Skin Patch Medicine Market Research Report 2023
BUY CHAPTERS

Global Skin Patch Medicine Market Research Report 2025

Code: QYRE-Auto-38M16213
Report
May 2025
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Viatris
USB
Endo
Teva Pharmaceutical
Agile Therapeutics
Nitto Denko
Medherant
AdhexPharma
Amneal
Hikma
Sparsha Pharma
Luye Pharma Group
Novartis
AbbVie
Lead Chemical
Purdue Pharma
Mundipharma
Hisamatsu Pharmaceuticals
Iontopatch
Evernow
Alvogen Group

Skin Patch Medicine Market

The global market for Skin Patch Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A skin patch, also known as a transdermal patch, is a medical delivery system that administers medication through the skin and into the bloodstream.
North American market for Skin Patch Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Skin Patch Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Skin Patch Medicine include Johnson & Johnson, Viatris, Hisamatsu Pharmaceuticals, USB, Boehringer Ingelheim, Endo, Teva Pharmaceutical, Agile Therapeutics, Bayer, Nitto Denko, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Skin Patch Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Patch Medicine.
The Skin Patch Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Skin Patch Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Patch Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Skin Patch Medicine Market Report

Report Metric Details
Report Name Skin Patch Medicine Market
Segment by Type
  • Acrylic Adhesives
  • Silicone Adhesives
  • Hydrogel Adhesives
  • Other
Segment by Application
  • Pain Management
  • Smoking Cessation
  • Hormone Replacement Therapy
  • Cardiovascular Disorder
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, Viatris, Hisamatsu Pharmaceuticals, USB, Boehringer Ingelheim, Endo, Teva Pharmaceutical, Agile Therapeutics, Bayer, Nitto Denko, Iontopatch, Medherant, AdhexPharma, Evernow, Amneal, Hikma, Alvogen Group, Sparsha Pharma, Luye Pharma Group, Novartis AG, AbbVie, LEAD CHEMICAL, Purdue Pharma, Mundipharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Skin Patch Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Skin Patch Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Skin Patch Medicine Market report?

Ans: The main players in the Skin Patch Medicine Market are Johnson & Johnson, Viatris, Hisamatsu Pharmaceuticals, USB, Boehringer Ingelheim, Endo, Teva Pharmaceutical, Agile Therapeutics, Bayer, Nitto Denko, Iontopatch, Medherant, AdhexPharma, Evernow, Amneal, Hikma, Alvogen Group, Sparsha Pharma, Luye Pharma Group, Novartis AG, AbbVie, LEAD CHEMICAL, Purdue Pharma, Mundipharma

What are the Application segmentation covered in the Skin Patch Medicine Market report?

Ans: The Applications covered in the Skin Patch Medicine Market report are Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Others

What are the Type segmentation covered in the Skin Patch Medicine Market report?

Ans: The Types covered in the Skin Patch Medicine Market report are Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives, Other

1 Skin Patch Medicine Market Overview
1.1 Product Definition
1.2 Skin Patch Medicine by Type
1.2.1 Global Skin Patch Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acrylic Adhesives
1.2.3 Silicone Adhesives
1.2.4 Hydrogel Adhesives
1.2.5 Other
1.3 Skin Patch Medicine by Application
1.3.1 Global Skin Patch Medicine Market Value by Application (2024 VS 2031)
1.3.2 Pain Management
1.3.3 Smoking Cessation
1.3.4 Hormone Replacement Therapy
1.3.5 Cardiovascular Disorder
1.3.6 Others
1.4 Global Skin Patch Medicine Market Size Estimates and Forecasts
1.4.1 Global Skin Patch Medicine Revenue 2020-2031
1.4.2 Global Skin Patch Medicine Sales 2020-2031
1.4.3 Global Skin Patch Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Skin Patch Medicine Market Competition by Manufacturers
2.1 Global Skin Patch Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Skin Patch Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Skin Patch Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Skin Patch Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Skin Patch Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Skin Patch Medicine, Product Type & Application
2.7 Global Key Manufacturers of Skin Patch Medicine, Date of Enter into This Industry
2.8 Global Skin Patch Medicine Market Competitive Situation and Trends
2.8.1 Global Skin Patch Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Skin Patch Medicine Players Market Share by Revenue
2.8.3 Global Skin Patch Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Skin Patch Medicine Market Scenario by Region
3.1 Global Skin Patch Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Skin Patch Medicine Sales by Region: 2020-2031
3.2.1 Global Skin Patch Medicine Sales by Region: 2020-2025
3.2.2 Global Skin Patch Medicine Sales by Region: 2026-2031
3.3 Global Skin Patch Medicine Revenue by Region: 2020-2031
3.3.1 Global Skin Patch Medicine Revenue by Region: 2020-2025
3.3.2 Global Skin Patch Medicine Revenue by Region: 2026-2031
3.4 North America Skin Patch Medicine Market Facts & Figures by Country
3.4.1 North America Skin Patch Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Skin Patch Medicine Sales by Country (2020-2031)
3.4.3 North America Skin Patch Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Skin Patch Medicine Market Facts & Figures by Country
3.5.1 Europe Skin Patch Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Skin Patch Medicine Sales by Country (2020-2031)
3.5.3 Europe Skin Patch Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Skin Patch Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Skin Patch Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Skin Patch Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Skin Patch Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Skin Patch Medicine Market Facts & Figures by Country
3.7.1 Latin America Skin Patch Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Skin Patch Medicine Sales by Country (2020-2031)
3.7.3 Latin America Skin Patch Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Skin Patch Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Skin Patch Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Skin Patch Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Skin Patch Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Skin Patch Medicine Sales by Type (2020-2031)
4.1.1 Global Skin Patch Medicine Sales by Type (2020-2025)
4.1.2 Global Skin Patch Medicine Sales by Type (2026-2031)
4.1.3 Global Skin Patch Medicine Sales Market Share by Type (2020-2031)
4.2 Global Skin Patch Medicine Revenue by Type (2020-2031)
4.2.1 Global Skin Patch Medicine Revenue by Type (2020-2025)
4.2.2 Global Skin Patch Medicine Revenue by Type (2026-2031)
4.2.3 Global Skin Patch Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Skin Patch Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Skin Patch Medicine Sales by Application (2020-2031)
5.1.1 Global Skin Patch Medicine Sales by Application (2020-2025)
5.1.2 Global Skin Patch Medicine Sales by Application (2026-2031)
5.1.3 Global Skin Patch Medicine Sales Market Share by Application (2020-2031)
5.2 Global Skin Patch Medicine Revenue by Application (2020-2031)
5.2.1 Global Skin Patch Medicine Revenue by Application (2020-2025)
5.2.2 Global Skin Patch Medicine Revenue by Application (2026-2031)
5.2.3 Global Skin Patch Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Skin Patch Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Skin Patch Medicine Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Company Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Viatris Skin Patch Medicine Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Hisamatsu Pharmaceuticals
6.3.1 Hisamatsu Pharmaceuticals Company Information
6.3.2 Hisamatsu Pharmaceuticals Description and Business Overview
6.3.3 Hisamatsu Pharmaceuticals Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hisamatsu Pharmaceuticals Skin Patch Medicine Product Portfolio
6.3.5 Hisamatsu Pharmaceuticals Recent Developments/Updates
6.4 USB
6.4.1 USB Company Information
6.4.2 USB Description and Business Overview
6.4.3 USB Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 USB Skin Patch Medicine Product Portfolio
6.4.5 USB Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Company Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boehringer Ingelheim Skin Patch Medicine Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Endo
6.6.1 Endo Company Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Endo Skin Patch Medicine Product Portfolio
6.6.5 Endo Recent Developments/Updates
6.7 Teva Pharmaceutical
6.7.1 Teva Pharmaceutical Company Information
6.7.2 Teva Pharmaceutical Description and Business Overview
6.7.3 Teva Pharmaceutical Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical Skin Patch Medicine Product Portfolio
6.7.5 Teva Pharmaceutical Recent Developments/Updates
6.8 Agile Therapeutics
6.8.1 Agile Therapeutics Company Information
6.8.2 Agile Therapeutics Description and Business Overview
6.8.3 Agile Therapeutics Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Agile Therapeutics Skin Patch Medicine Product Portfolio
6.8.5 Agile Therapeutics Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Skin Patch Medicine Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Nitto Denko
6.10.1 Nitto Denko Company Information
6.10.2 Nitto Denko Description and Business Overview
6.10.3 Nitto Denko Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nitto Denko Skin Patch Medicine Product Portfolio
6.10.5 Nitto Denko Recent Developments/Updates
6.11 Iontopatch
6.11.1 Iontopatch Company Information
6.11.2 Iontopatch Description and Business Overview
6.11.3 Iontopatch Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Iontopatch Skin Patch Medicine Product Portfolio
6.11.5 Iontopatch Recent Developments/Updates
6.12 Medherant
6.12.1 Medherant Company Information
6.12.2 Medherant Description and Business Overview
6.12.3 Medherant Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Medherant Skin Patch Medicine Product Portfolio
6.12.5 Medherant Recent Developments/Updates
6.13 AdhexPharma
6.13.1 AdhexPharma Company Information
6.13.2 AdhexPharma Description and Business Overview
6.13.3 AdhexPharma Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 AdhexPharma Skin Patch Medicine Product Portfolio
6.13.5 AdhexPharma Recent Developments/Updates
6.14 Evernow
6.14.1 Evernow Company Information
6.14.2 Evernow Description and Business Overview
6.14.3 Evernow Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Evernow Skin Patch Medicine Product Portfolio
6.14.5 Evernow Recent Developments/Updates
6.15 Amneal
6.15.1 Amneal Company Information
6.15.2 Amneal Description and Business Overview
6.15.3 Amneal Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Amneal Skin Patch Medicine Product Portfolio
6.15.5 Amneal Recent Developments/Updates
6.16 Hikma
6.16.1 Hikma Company Information
6.16.2 Hikma Description and Business Overview
6.16.3 Hikma Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hikma Skin Patch Medicine Product Portfolio
6.16.5 Hikma Recent Developments/Updates
6.17 Alvogen Group
6.17.1 Alvogen Group Company Information
6.17.2 Alvogen Group Description and Business Overview
6.17.3 Alvogen Group Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Alvogen Group Skin Patch Medicine Product Portfolio
6.17.5 Alvogen Group Recent Developments/Updates
6.18 Sparsha Pharma
6.18.1 Sparsha Pharma Company Information
6.18.2 Sparsha Pharma Description and Business Overview
6.18.3 Sparsha Pharma Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Sparsha Pharma Skin Patch Medicine Product Portfolio
6.18.5 Sparsha Pharma Recent Developments/Updates
6.19 Luye Pharma Group
6.19.1 Luye Pharma Group Company Information
6.19.2 Luye Pharma Group Description and Business Overview
6.19.3 Luye Pharma Group Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Luye Pharma Group Skin Patch Medicine Product Portfolio
6.19.5 Luye Pharma Group Recent Developments/Updates
6.20 Novartis AG
6.20.1 Novartis AG Company Information
6.20.2 Novartis AG Description and Business Overview
6.20.3 Novartis AG Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Novartis AG Skin Patch Medicine Product Portfolio
6.20.5 Novartis AG Recent Developments/Updates
6.21 AbbVie
6.21.1 AbbVie Company Information
6.21.2 AbbVie Description and Business Overview
6.21.3 AbbVie Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.21.4 AbbVie Skin Patch Medicine Product Portfolio
6.21.5 AbbVie Recent Developments/Updates
6.22 LEAD CHEMICAL
6.22.1 LEAD CHEMICAL Company Information
6.22.2 LEAD CHEMICAL Description and Business Overview
6.22.3 LEAD CHEMICAL Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.22.4 LEAD CHEMICAL Skin Patch Medicine Product Portfolio
6.22.5 LEAD CHEMICAL Recent Developments/Updates
6.23 Purdue Pharma
6.23.1 Purdue Pharma Company Information
6.23.2 Purdue Pharma Description and Business Overview
6.23.3 Purdue Pharma Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Purdue Pharma Skin Patch Medicine Product Portfolio
6.23.5 Purdue Pharma Recent Developments/Updates
6.24 Mundipharma
6.24.1 Mundipharma Company Information
6.24.2 Mundipharma Description and Business Overview
6.24.3 Mundipharma Skin Patch Medicine Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Mundipharma Skin Patch Medicine Product Portfolio
6.24.5 Mundipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Skin Patch Medicine Industry Chain Analysis
7.2 Skin Patch Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Skin Patch Medicine Production Mode & Process Analysis
7.4 Skin Patch Medicine Sales and Marketing
7.4.1 Skin Patch Medicine Sales Channels
7.4.2 Skin Patch Medicine Distributors
7.5 Skin Patch Medicine Customer Analysis
8 Skin Patch Medicine Market Dynamics
8.1 Skin Patch Medicine Industry Trends
8.2 Skin Patch Medicine Market Drivers
8.3 Skin Patch Medicine Market Challenges
8.4 Skin Patch Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Viatris
USB
Endo
Teva Pharmaceutical
Agile Therapeutics
Nitto Denko
Medherant
AdhexPharma
Amneal
Hikma
Sparsha Pharma
Luye Pharma Group
Novartis
AbbVie
Lead Chemical
Purdue Pharma
Mundipharma
Hisamatsu Pharmaceuticals
Iontopatch
Evernow
Alvogen Group
List of Tables
 Table 1. Global Skin Patch Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Skin Patch Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Skin Patch Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Skin Patch Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Skin Patch Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Skin Patch Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Skin Patch Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Skin Patch Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Skin Patch Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Skin Patch Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Skin Patch Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Skin Patch Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Skin Patch Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Patch Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Skin Patch Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Skin Patch Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Skin Patch Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Skin Patch Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Skin Patch Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Skin Patch Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Skin Patch Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Skin Patch Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Skin Patch Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Skin Patch Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Skin Patch Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Skin Patch Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Skin Patch Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Skin Patch Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Skin Patch Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Skin Patch Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Skin Patch Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Skin Patch Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Skin Patch Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Skin Patch Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Skin Patch Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Skin Patch Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Skin Patch Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Skin Patch Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Skin Patch Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Skin Patch Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Skin Patch Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Skin Patch Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Skin Patch Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Skin Patch Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Skin Patch Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Skin Patch Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Skin Patch Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Skin Patch Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Skin Patch Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Skin Patch Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Skin Patch Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Skin Patch Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Skin Patch Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Skin Patch Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Skin Patch Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Skin Patch Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Skin Patch Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Skin Patch Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Skin Patch Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Skin Patch Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Skin Patch Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Skin Patch Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Skin Patch Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Skin Patch Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Skin Patch Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Skin Patch Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Skin Patch Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Skin Patch Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Skin Patch Medicine Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. Viatris Company Information
 Table 76. Viatris Description and Business Overview
 Table 77. Viatris Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Viatris Skin Patch Medicine Product
 Table 79. Viatris Recent Developments/Updates
 Table 80. Hisamatsu Pharmaceuticals Company Information
 Table 81. Hisamatsu Pharmaceuticals Description and Business Overview
 Table 82. Hisamatsu Pharmaceuticals Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hisamatsu Pharmaceuticals Skin Patch Medicine Product
 Table 84. Hisamatsu Pharmaceuticals Recent Developments/Updates
 Table 85. USB Company Information
 Table 86. USB Description and Business Overview
 Table 87. USB Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. USB Skin Patch Medicine Product
 Table 89. USB Recent Developments/Updates
 Table 90. Boehringer Ingelheim Company Information
 Table 91. Boehringer Ingelheim Description and Business Overview
 Table 92. Boehringer Ingelheim Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Boehringer Ingelheim Skin Patch Medicine Product
 Table 94. Boehringer Ingelheim Recent Developments/Updates
 Table 95. Endo Company Information
 Table 96. Endo Description and Business Overview
 Table 97. Endo Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Endo Skin Patch Medicine Product
 Table 99. Endo Recent Developments/Updates
 Table 100. Teva Pharmaceutical Company Information
 Table 101. Teva Pharmaceutical Description and Business Overview
 Table 102. Teva Pharmaceutical Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical Skin Patch Medicine Product
 Table 104. Teva Pharmaceutical Recent Developments/Updates
 Table 105. Agile Therapeutics Company Information
 Table 106. Agile Therapeutics Description and Business Overview
 Table 107. Agile Therapeutics Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Agile Therapeutics Skin Patch Medicine Product
 Table 109. Agile Therapeutics Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bayer Skin Patch Medicine Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Nitto Denko Company Information
 Table 116. Nitto Denko Description and Business Overview
 Table 117. Nitto Denko Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Nitto Denko Skin Patch Medicine Product
 Table 119. Nitto Denko Recent Developments/Updates
 Table 120. Iontopatch Company Information
 Table 121. Iontopatch Description and Business Overview
 Table 122. Iontopatch Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Iontopatch Skin Patch Medicine Product
 Table 124. Iontopatch Recent Developments/Updates
 Table 125. Medherant Company Information
 Table 126. Medherant Description and Business Overview
 Table 127. Medherant Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Medherant Skin Patch Medicine Product
 Table 129. Medherant Recent Developments/Updates
 Table 130. AdhexPharma Company Information
 Table 131. AdhexPharma Description and Business Overview
 Table 132. AdhexPharma Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. AdhexPharma Skin Patch Medicine Product
 Table 134. AdhexPharma Recent Developments/Updates
 Table 135. Evernow Company Information
 Table 136. Evernow Description and Business Overview
 Table 137. Evernow Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Evernow Skin Patch Medicine Product
 Table 139. Evernow Recent Developments/Updates
 Table 140. Amneal Company Information
 Table 141. Amneal Description and Business Overview
 Table 142. Amneal Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Amneal Skin Patch Medicine Product
 Table 144. Amneal Recent Developments/Updates
 Table 145. Hikma Company Information
 Table 146. Hikma Description and Business Overview
 Table 147. Hikma Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Hikma Skin Patch Medicine Product
 Table 149. Hikma Recent Developments/Updates
 Table 150. Alvogen Group Company Information
 Table 151. Alvogen Group Description and Business Overview
 Table 152. Alvogen Group Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Alvogen Group Skin Patch Medicine Product
 Table 154. Alvogen Group Recent Developments/Updates
 Table 155. Sparsha Pharma Company Information
 Table 156. Sparsha Pharma Description and Business Overview
 Table 157. Sparsha Pharma Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Sparsha Pharma Skin Patch Medicine Product
 Table 159. Sparsha Pharma Recent Developments/Updates
 Table 160. Luye Pharma Group Company Information
 Table 161. Luye Pharma Group Description and Business Overview
 Table 162. Luye Pharma Group Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Luye Pharma Group Skin Patch Medicine Product
 Table 164. Luye Pharma Group Recent Developments/Updates
 Table 165. Novartis AG Company Information
 Table 166. Novartis AG Description and Business Overview
 Table 167. Novartis AG Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Novartis AG Skin Patch Medicine Product
 Table 169. Novartis AG Recent Developments/Updates
 Table 170. AbbVie Company Information
 Table 171. AbbVie Description and Business Overview
 Table 172. AbbVie Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. AbbVie Skin Patch Medicine Product
 Table 174. AbbVie Recent Developments/Updates
 Table 175. LEAD CHEMICAL Company Information
 Table 176. LEAD CHEMICAL Description and Business Overview
 Table 177. LEAD CHEMICAL Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. LEAD CHEMICAL Skin Patch Medicine Product
 Table 179. LEAD CHEMICAL Recent Developments/Updates
 Table 180. Purdue Pharma Company Information
 Table 181. Purdue Pharma Description and Business Overview
 Table 182. Purdue Pharma Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Purdue Pharma Skin Patch Medicine Product
 Table 184. Purdue Pharma Recent Developments/Updates
 Table 185. Mundipharma Company Information
 Table 186. Mundipharma Description and Business Overview
 Table 187. Mundipharma Skin Patch Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Mundipharma Skin Patch Medicine Product
 Table 189. Mundipharma Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Skin Patch Medicine Distributors List
 Table 193. Skin Patch Medicine Customers List
 Table 194. Skin Patch Medicine Market Trends
 Table 195. Skin Patch Medicine Market Drivers
 Table 196. Skin Patch Medicine Market Challenges
 Table 197. Skin Patch Medicine Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Skin Patch Medicine
 Figure 2. Global Skin Patch Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Skin Patch Medicine Market Share by Type: 2024 & 2031
 Figure 4. Acrylic Adhesives Product Picture
 Figure 5. Silicone Adhesives Product Picture
 Figure 6. Hydrogel Adhesives Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Skin Patch Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Skin Patch Medicine Market Share by Application: 2024 & 2031
 Figure 10. Pain Management
 Figure 11. Smoking Cessation
 Figure 12. Hormone Replacement Therapy
 Figure 13. Cardiovascular Disorder
 Figure 14. Others
 Figure 15. Global Skin Patch Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Skin Patch Medicine Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Skin Patch Medicine Sales (2020-2031) & (K Units)
 Figure 18. Global Skin Patch Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 19. Skin Patch Medicine Report Years Considered
 Figure 20. Skin Patch Medicine Sales Share by Manufacturers in 2024
 Figure 21. Global Skin Patch Medicine Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Skin Patch Medicine Players: Market Share by Revenue in Skin Patch Medicine in 2024
 Figure 23. Skin Patch Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Skin Patch Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Skin Patch Medicine Sales Market Share by Country (2020-2031)
 Figure 26. North America Skin Patch Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. United States Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Skin Patch Medicine Sales Market Share by Country (2020-2031)
 Figure 30. Europe Skin Patch Medicine Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Skin Patch Medicine Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Skin Patch Medicine Revenue Market Share by Region (2020-2031)
 Figure 38. China Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Skin Patch Medicine Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Skin Patch Medicine Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Skin Patch Medicine Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Skin Patch Medicine Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Skin Patch Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Skin Patch Medicine by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Skin Patch Medicine by Type (2020-2031)
 Figure 57. Global Skin Patch Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Skin Patch Medicine by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Skin Patch Medicine by Application (2020-2031)
 Figure 60. Global Skin Patch Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 61. Skin Patch Medicine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions